Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer to sell USD 3 billion stake in Haleon

Ruchika Sharma15 Jan 2025 2:30 PM IST

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 billion) in the British...

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole

Ruchika Sharma15 Jan 2025 1:30 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...

CDSCO grants license to Time Medical International Ventures (India) for manufacturing, distributing MRI systems

Ruchika Sharma15 Jan 2025 12:30 PM IST

Vishakapatnam: Time Medical International Ventures (India) Private Limited, a Wholly Owned Subsidiary of Fischer Medical Ventures Limited, a Make...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

JnJ to acquire Intra-Cellular Therapies for USD 14.6 billion

Ruchika Sharma15 Jan 2025 11:30 AM IST

New Brunswick: Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under...

Pfizer Sasanlimab, BCG combo improves event-free survival in patients with BCG-Naive, High-Risk Non-Muscle Invasive Bladder Cancer

Ruchika Sharma15 Jan 2025 10:30 AM IST

New York: Pfizer Inc. has announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational...

Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion deal

Copycat weight-loss drugs: Eli Lilly sues two medical spas

Ruchika Sharma14 Jan 2025 5:28 PM IST

Two medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in...

GSK buys IDRx for up to USD 1.15 billion

Eli Lilly to acquire Scorpion Therapeutics mutant-selective PI3Kα inhibitor program

Ruchika Sharma14 Jan 2025 4:48 PM IST

Indianapolis: Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small molecule...

Roche gets negative EMA Committee opinion on Elevidys CMA

Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma

Ruchika Sharma14 Jan 2025 4:06 PM IST

Basel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...

AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancer

AstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA priority review in pretreated EGFR-mutated non-small cell lung cancer

Ruchika Sharma14 Jan 2025 2:30 PM IST

Datopotamab deruxtecan is a specifically engineered TROP2-directed DXd antibody drug conjugate discovered by Daiichi Sankyo.

Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma

Ruchika Sharma14 Jan 2025 1:30 PM IST

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine,...

GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNP

GSK to acquire IDRx for upto USD 1.15 billion

Ruchika Sharma14 Jan 2025 12:45 PM IST

London: GSK plc has announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage...

Lupin unveils Glucagon for Injection for severe hypoglycemia in patients with diabetes mellitus in US

Lupin unveils pregnancy prevention drug Minzoya in US

Ruchika Sharma14 Jan 2025 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok